BRCA2 and breast cancer: Early-onset breast cancers often arise from rare germline pathogenic variants (P variants), which is why genetics, such as the presence of a germline P variant in BRCA1 or BRCA2 genes, is used to identify women at high risk.3,5,6 We hypothesized that genetics could also identify a subset of women at decreased risk.